RTC
HZNP

Riverview Trust Company’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Riverview Trust Company’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-188
Closed -$21.8K – 672
2023
Q3 		$21.8K Hold
188
– – 0.02% 363
2023
Q2 		$19.3K Hold
188
– – 0.02% 377
2023
Q1 		$20.5K Hold
188
– – 0.02% 339
2022
Q4 		$21K Buy
+188
New +$15.6K 0.02% 336
2022
Q3 		– Sell
-184
Closed -$15K – 931
2022
Q2 		$15K Hold
184
– – 0.01% 502
2022
Q1 		$19K Buy
+184
New +$17.9K 0.01% 520

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Riverview Trust Company's HZNP Position: Q4 2023 in Review

Riverview Trust Company sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 188 shares — an estimated $21.8K sold.

Riverview Trust Company first reported a position in HZNP in Q1 2022 and held it in 6 quarters. The position peaked at $21.8K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Riverview Trust Company reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Riverview Trust Company sold 188 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $21.8K.
  • Riverview Trust Company first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2022 and held it in 6 quarters.
  • Riverview Trust Company's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $21.8K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Riverview Trust Company's 13F filing for Q4 2023, filed 24 Jan 2024.